Pages that link to "Q41004145"
Jump to navigation
Jump to search
The following pages link to Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia (Q41004145):
Displaying 27 items.
- DNA Damage Response and Autophagy: A Meaningful Partnership (Q28080294) (← links)
- Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model (Q37330859) (← links)
- Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation (Q37720022) (← links)
- Verapamil treatment induces cytoprotective autophagy by modulating cellular metabolism (Q38710573) (← links)
- Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia (Q41335421) (← links)
- Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome (Q41816813) (← links)
- Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine (Q41913197) (← links)
- Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia (Q42517286) (← links)
- Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia (Q48592284) (← links)
- HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLC. (Q52316687) (← links)
- The multifaceted role of autophagy in cancer and the microenvironment (Q57291210) (← links)
- Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer (Q61796271) (← links)
- CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma (Q61805288) (← links)
- Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism (Q64109908) (← links)
- Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma (Q64243914) (← links)
- Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions (Q64276608) (← links)
- Elevated VMP1 expression in acute myeloid leukemia amplifies autophagy and is protective against venetoclax-induced apoptosis (Q64290693) (← links)
- MicroRNA‑154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7. (Q64896429) (← links)
- Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia (Q90389782) (← links)
- Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia (Q90462212) (← links)
- Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia (Q91936391) (← links)
- Disrupting the LC3 Interaction Region (LIR) Binding of Selective Autophagy Receptors Sensitizes AML Cell Lines to Cytarabine (Q91975855) (← links)
- BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment (Q92099049) (← links)
- LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML (Q92143839) (← links)
- Clinical significance of BECLIN1 and ATG5 expression in acute myeloid leukemia patients (Q92645648) (← links)
- Targeting Metabolic Reprogramming in Acute Myeloid Leukemia (Q92874380) (← links)
- Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia (Q100945788) (← links)